本期内容提示:
1、$Taysha Gene(TSHA)与安斯泰来合作,被低估的基因疗法板块是否会迎来估值修复?
2、$赛拉喜(CYCC)数据发布在即,是否有抄底机会?
3、$Unity(U)、$Carvana Co.(CVNA)、$谷歌A(GOOGL)期权异动,后续走势如何看?
$网易(NTES)$ $...查看全文
为灵魂插上翅膀2022-08-11 11:30
回复@好林泉付与闲人: 发了财报,抗癌药各项研发进展不错,FDA也给面扩大了患者试用剂量,手里现金2900万美元,现在估值1300万美元,所以国外韭菜们一致看好……另外就是流通股只有700万,刨去机构持有,估计流通也就不足500万股,所以有一定几率爆上 $赛拉喜(CYCC)$//@好林泉付与闲人:回复@为灵魂...查看全文
牛唐2022-01-07 10:44
医药板块速评(2022.01.06)
本期内容提示:
1、疫情概念股普跌,哪些标的还有配置机会?
2、$居里(CRIS)股价暴跌,是否有抄底机会?
3、$Otonomy(OTIC)、$Affimed(AFMD)、$赛拉喜(CYCC)等公司更新研发进度,哪些标的今年有翻倍机会?
$百济神州-U(SH688235)$ $滴滴(DIDI)...查看全文
牛唐2021-01-29 17:10
医药板块速评(2021.01.28)
1、又一家机构扎堆的现金价公司,可否复制$赛拉喜(CYCC)的走势?
2、双抗白马$Zymeworks(ZYME)暴跌,可否抄底?
3、$Otonomy(OTIC)$ 重磅数据在前,可否参与?
$游戏驿站(GME)$ $百度(BIDU)$查看全文
$Cyclacel Pharmaceuticals, Inc.(CYCC)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2017-06-30 AccNo: 0001571049-17-006442 Size: 1 MB 网页链接
$Cyclacel Pharmaceuticals, Inc.(CYCC)$ 8-K - Current report Filed: 2017-06-30 AccNo: 0001144204-17-035271 Size: 17 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Cyclacel Pharmaceuticals, Inc.(CYCC)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-06-29 AccNo: 0001144204-17-034929 Size: 90 KB 网页链接
$Cyclacel Pharmaceuticals(CYCC)$ 8-K - Current report Filed: 2017-06-27 AccNo: 0001144204-17-034440 Size: 30 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01...
$Cyclacel Pharmaceuticals(CYCC)$ 8-K - Current report Filed: 2017-06-01 AccNo: 0001571049-17-005582 Size: 33 KBItem 5.07: Submission of Matters to a Vote of Security HoldersItem 8.01: Other Events 网页链接
$Cyclacel Pharmaceuticals(CYCC)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2017-05-26 AccNo: 0001571049-17-005444 Size: 835 KB 网页链接
$Cyclacel Pharmaceuticals(CYCC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-12 AccNo: 0001571049-17-004966 Size: 1 MB 网页链接
$Cyclacel Pharmaceuticals(CYCC)$ 8-K - Current report Filed: 2017-05-11 AccNo: 0001571049-17-004882 Size: 104 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cyclacel Pharmaceuticals(CYCC)$ 美东时间 2017-05-11 盘后 披露财报,预期EPS n/a 网页链接
$Cyclacel Pharmaceuticals(CYCC)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-04-12 AccNo: 0001571049-17-003521 Size: 1 MB 网页链接